医学知识

订阅

MedSci主页 / 所有栏目 / 医学知识

NEJM：每周一次艾塞那肽治疗对2型糖尿病患者的心血管预后

2017-10-11 MedSci MedSci原创

糖尿病艾塞那肽糖尿病
关注

原始出处：Rury R. Holman, F.Med.Sci.et al.Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.本文系梅斯医学（MEDSCI）原创编译整理，转载需授权！

原始出处：

Rury R. Holman, F.Med.Sci.et al.Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.
本文系梅斯医学（MEDSCI）原创编译整理，转载需授权！

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1383348, encodeId=45ec138334877, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1101, encryptionId=196a1101f7, topicName=2型糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec19483, createdName=aids213, createdTime=Fri Oct 13 07:24:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1393614, encodeId=e285139361404, content=<a href='/topic/show?id=4a9886e56ed' target=_blank style='color:#2F92EE;'>#艾塞那肽#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86756, encryptionId=4a9886e56ed, topicName=艾塞那肽)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/UdV6ialcayj7Qv8RQm1mVfNYPKxjiaolxwglAZpCo6CwjTicOroW2Xb0Kxnc65viaxGpkuqHW7WzzbYgRLw3qooDoA/132, createdBy=04c22500137, createdName=紫砂壶, createdTime=Fri Oct 13 07:24:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1474310, encodeId=70be14e431015, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Fri Oct 13 07:24:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1508630, encodeId=4d991508630a8, content=<a href='/topic/show?id=884c51916cd' target=_blank style='color:#2F92EE;'>#心血管预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51916, encryptionId=884c51916cd, topicName=心血管预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de8d9990502, createdName=xiaogang320, createdTime=Fri Oct 13 07:24:00 CST 2017, time=2017-10-13, status=1, ipAttribution=)]
    2017-10-13 aids213

    #2型糖尿病患者#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1383348, encodeId=45ec138334877, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1101, encryptionId=196a1101f7, topicName=2型糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec19483, createdName=aids213, createdTime=Fri Oct 13 07:24:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1393614, encodeId=e285139361404, content=<a href='/topic/show?id=4a9886e56ed' target=_blank style='color:#2F92EE;'>#艾塞那肽#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86756, encryptionId=4a9886e56ed, topicName=艾塞那肽)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/UdV6ialcayj7Qv8RQm1mVfNYPKxjiaolxwglAZpCo6CwjTicOroW2Xb0Kxnc65viaxGpkuqHW7WzzbYgRLw3qooDoA/132, createdBy=04c22500137, createdName=紫砂壶, createdTime=Fri Oct 13 07:24:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1474310, encodeId=70be14e431015, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Fri Oct 13 07:24:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1508630, encodeId=4d991508630a8, content=<a href='/topic/show?id=884c51916cd' target=_blank style='color:#2F92EE;'>#心血管预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51916, encryptionId=884c51916cd, topicName=心血管预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de8d9990502, createdName=xiaogang320, createdTime=Fri Oct 13 07:24:00 CST 2017, time=2017-10-13, status=1, ipAttribution=)]
    2017-10-13 紫砂壶

    #艾塞那肽#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1383348, encodeId=45ec138334877, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1101, encryptionId=196a1101f7, topicName=2型糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec19483, createdName=aids213, createdTime=Fri Oct 13 07:24:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1393614, encodeId=e285139361404, content=<a href='/topic/show?id=4a9886e56ed' target=_blank style='color:#2F92EE;'>#艾塞那肽#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86756, encryptionId=4a9886e56ed, topicName=艾塞那肽)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/UdV6ialcayj7Qv8RQm1mVfNYPKxjiaolxwglAZpCo6CwjTicOroW2Xb0Kxnc65viaxGpkuqHW7WzzbYgRLw3qooDoA/132, createdBy=04c22500137, createdName=紫砂壶, createdTime=Fri Oct 13 07:24:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1474310, encodeId=70be14e431015, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Fri Oct 13 07:24:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1508630, encodeId=4d991508630a8, content=<a href='/topic/show?id=884c51916cd' target=_blank style='color:#2F92EE;'>#心血管预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51916, encryptionId=884c51916cd, topicName=心血管预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de8d9990502, createdName=xiaogang320, createdTime=Fri Oct 13 07:24:00 CST 2017, time=2017-10-13, status=1, ipAttribution=)]
    2017-10-13 xue8604

    #糖尿病患者#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1383348, encodeId=45ec138334877, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1101, encryptionId=196a1101f7, topicName=2型糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec19483, createdName=aids213, createdTime=Fri Oct 13 07:24:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1393614, encodeId=e285139361404, content=<a href='/topic/show?id=4a9886e56ed' target=_blank style='color:#2F92EE;'>#艾塞那肽#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86756, encryptionId=4a9886e56ed, topicName=艾塞那肽)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/UdV6ialcayj7Qv8RQm1mVfNYPKxjiaolxwglAZpCo6CwjTicOroW2Xb0Kxnc65viaxGpkuqHW7WzzbYgRLw3qooDoA/132, createdBy=04c22500137, createdName=紫砂壶, createdTime=Fri Oct 13 07:24:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1474310, encodeId=70be14e431015, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Fri Oct 13 07:24:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1508630, encodeId=4d991508630a8, content=<a href='/topic/show?id=884c51916cd' target=_blank style='color:#2F92EE;'>#心血管预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51916, encryptionId=884c51916cd, topicName=心血管预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de8d9990502, createdName=xiaogang320, createdTime=Fri Oct 13 07:24:00 CST 2017, time=2017-10-13, status=1, ipAttribution=)]
    2017-10-13 xiaogang320

    #心血管预后#

    0

相关资讯

Nat Commun：糖尿病治疗的新技术，无明显副作用

糖尿病在这样缺氧条件下，身体一般会产生新的血管来帮助缓解症状，但结果往往是渗漏的、功能紊乱的血管，使糟糕的事情变得更糟。

适合糖友的3种运动 三个部位易骨折要护好

糖尿病是一种严重危害健康的常见慢病。随着我国人口老龄化加快及饮食结构的改变，糖尿病患者正在快速增多。中国疾控中心最新报告显示，中国成人糖尿病的患病率为10.6%，我国有糖尿病患者近1亿。

Stroke：胰岛β细胞功能难道与非糖尿病患者缺血性脑卒中预后也有关系？

胰岛B细胞是胰岛细胞的一种，属内分泌细胞，约占胰岛细胞总数的70%，主要位于胰岛中央部，能分泌胰岛素，起调节血糖含量的作用。胰岛B细胞功能受损，胰岛素分泌绝对或相对不足，从而引发糖尿病。胰岛β细胞功能异常是II型糖尿病发生发展的一项重要因素。本研究旨在评估胰岛β细胞功能与缺血性脑卒中非糖尿病患者预后间的相关性，并将结果发表在Stroke上。

Nat Immunol： 巴黎科学家确定预防和治疗糖尿病新靶点，能否带来颠覆性发展？

来自巴黎笛卡尔大学的研究人员们发现，1型糖尿病在发病之前MAIT淋巴细胞发生了变化，相关细胞粘膜以及能够识别这一元素的微生物有望成为早期检测和预防疾病的新生物标志物，新研究发表在《自然免疫学》杂志中。

JAMA：儿童及青少年I型糖尿病患者使用胰岛素泵可显著降低严重低血糖以及糖尿病酮症酸中毒风险

研究认为，对于儿童和青少年I型糖尿病患者，使用胰岛素泵治疗可降低严重低血糖和糖尿病酮症酸中毒的发生率

只测空腹血糖不查餐后血糖，半数糖尿病被漏诊

以往糖尿病患者察觉自己有病，是由于多食多饮或体重减轻，此时往往已经延误了治疗。随着人们健康意识的提高，空腹血糖检测成为常规体检项目，而对于餐后血糖，人们大多并不重视。中国糖尿病及糖尿病前期最新流行病学数据显示，2013年中国成人糖尿病患病率为10.9%，糖尿病前期流行率达35.7%，其中70%的人群是以餐后血糖升高为主。而在所有糖尿病患者中，仅有36.5%已知自己患病。为什么有这么多糖尿病人不知自